ESLA Estrella Immunopharma, Inc.
Healthcare$1.15-0.86%ClosedMarket Cap: $49.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-9.27
P/S
0.00
EV/EBITDA
-3.65
DCF Value
$0.02
FCF Yield
-16.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
167.9%
ROA
-362.3%
ROIC
249.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-2.2M | $-2.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-613.2K | $-613.2K | $— | — |
| FY null | $0.00 | NaN% | $-13.1M | $-13.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.8M | $-4.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.5M | $-5.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.1M | $-2.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.1M | $-1.1M | $— | — |
| FY null | $0.00 | NaN% | $-8.8M | $-8.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.4M | $-3.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.9M | $-4.0M | $— | — |
| FY null | $0.00 | NaN% | $-7.3M | $-7.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-469.5K | $-469.5K | $— | — |